Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2016

01-10-2016 | Breast Oncology

A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer

Authors: Tina J. Hieken, MD, Robert W. Mutter, MD, James W. Jakub, MD, Judy C. Boughey, MD, Amy C. Degnim, MD, William R. Sukov, MD, Stephanie Childs, MD, Kimberly S. Corbin, MD, Keith M. Furutani, PhD, Thomas J. Whitaker, PhD, Sean S. Park, MD, PhD

Published in: Annals of Surgical Oncology | Issue 10/2016

Login to get access

Abstract

Background

Data support the use of accelerated partial-breast irradiation (APBI) for early-stage breast cancer. We initiated a prospective protocol for intraoperative APBI catheter placement using a multi-lumen strut-based device. We hypothesized that with intraoperative pathology assessment of margins and sentinel nodes, all locoregional treatment (surgery and APBI) could be completed within 10 days with acceptable complication rates and cosmesis.

Methods

Eligible patients included women age 50 years or older with clinical T1 estrogen receptor positive (ER+) sentinel lymph node (SLN)-negative invasive ductal cancer or pure ductal carcinoma in situ. Patients were prospectively registered. Cosmesis was assessed using photographs graded independently by three investigators for patients with photos taken 6 months or longer after treatment.

Results

From October 2012 to August 2015, we enrolled 123 patients; 110 (90 %) underwent intraoperative catheter placement, whereas 13 did not due to intraoperative pathology findings. 109 APBI patients (99 %) completed their prescribed radiotherapy within 5 days, and all their locoregional therapy within 9 days, whereas one patient with a delayed positive SLN received only boost radiotherapy via catheter followed by conventional whole breast radiation. The 30-day complication rate was 6 %. In 81 patients with at least one-year followup, complications occurred in 14 (17 %) (including infection in five patients and symptomatic seroma in five patients) and correlated with device size (p = 0.05) but not with tumor size or location. The local recurrence rate was 1.8 % (two patients). Scored cosmesis was excellent or good in 88 % and fair in 12 % of patients.

Conclusions

A protocol for intraoperative strut-based APBI catheter placement using careful patient selection and intraoperative pathology assessment can deliver efficient, effective treatment for early breast cancer.
Literature
1.
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRefPubMed
2.
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Eng J Med. 2002;347:1227–32.CrossRef
3.
Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.CrossRefPubMed
4.
5.
Smith GL, Shih YC, Xu Y, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010;116:734–41.CrossRefPubMed
6.
Mac Bride MB, Neal L, Dilaveri CA, Sandhu NP, Hieken TJ, Ghosh K, Wahner-Roedler DL. Factors associated with surgical decision making in women with early-stage breast cancer: a literature review. J Women’s Health. 2013;22:236–42.CrossRef
7.
Pan IW, Smith BD, Shih YC. Factors contributing to underuse of radiation among younger women with breast cancer. J Natl Cancer Inst. 2014;106:djt340.
8.
Dilaveri CA, Sandhu NP, Neal L, et al. Medical factors influencing decision making regarding radiation therapy for breast cancer. Int J Women’s Health. 2014;6:945–54.CrossRef
9.
Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-a randomised trial. Lancet. 2014;383:603–13.CrossRefPubMed
10.
Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387:229–38.CrossRefPubMed
11.
Beitsch PD, Shaitelman SF, Vicini FA. Accelerated partial breast irradiation. J Surg Oncol. 2011;103:362–8.CrossRef
12.
Hepel JT, Wazer DE. A comparison of brachytherapy techniques for partial breast irradiation. Brachytherapy. 2012;11:163–75.CrossRefPubMed
13.
Abbott AM, Habermann EB, Tuttle TM. Trends in the use of implantable accelerated partial breast irradiation therapy for early-stage breast cancer in the United States. Cancer. 2011;117:3305–10.CrossRefPubMed
14.
Ferreiro JA, Myers JL, Bostwick DG. Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc. 1995;70:1137–41.CrossRefPubMed
15.
Gal AA. The centennial anniversary of the frozen section technique at the Mayo Clinic. Arch Pathol Lab Med. 2005;129:1532–5.PubMed
16.
Boughey JC, Hieken TJ, Jakub JW, et al. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014;156:190–7.CrossRefPubMed
17.
Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YC, etal. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307:1827–37.PubMedPubMedCentral
18.
Klepczyk LC, Keene KS, De Los Santos JF. Accelerated partial breast irradiation for early-stage breast cancer: controversies and current indications for use. Curr Treat Options Oncol. 2013;14:51–65.CrossRef
19.
Rosenkranz KM, Tsui E, McCabe EB, Gui J, Underhill K, Barth RJ Jr. Increased rates of long-term complications after MammoSite brachytherapy compared with whole breast radiation therapy. J Am Coll Surg. 2013;217:497–502.CrossRefPubMed
20.
Ajkay N, Collett AE, Bloomquist EV, Gracely EJ, Frazier TG, Barrio AV. A comparison of complication rates in early-stage breast cancer patients treated with brachytherapy versus whole-breast irradiation. Ann Surg Oncol. 2015;22:1140–5.CrossRefPubMed
21.
Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001.CrossRefPubMed
22.
Shah C, Vicini F, Wazer DE, Arthur D, Patel RR. The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy. 2013;12:267–77.CrossRefPubMed
23.
24.
Polgar C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94:264–73.CrossRefPubMed
25.
Hieken TJ, Trull BC, Boughey JC, Jones KN, Reynolds CA, Shah SS, et al. Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery. 2013;154:831–8.CrossRefPubMed
26.
Al-Hilli Z, Hieken TJ, Boughey JC. Axillary ultrasound in the management of the newly diagnosed breast cancer patient. Breast J. 2015;21:634–41.CrossRefPubMed
27.
Hieken TJ. The promise of axillary imaging in individualized surgical management of breast cancer patients: another step forward. Ann Surg Oncol. 2014;21:3369–71.CrossRefPubMed
28.
29.
Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer: long-term cosmetic results. Arch Surg. 1989;124:153–7.CrossRefPubMed
30.
Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial- or whole-breast irradiation for low-risk invasive breast carcinoma: 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702.CrossRefPubMed
31.
Antonucci JV, Wallace M, Goldstein NS, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74:447–52.CrossRefPubMed
32.
Wobb JL, Shah C, Chen PY, Wallace M, Ye H, Jawad MS, et al. Brachytherapy-based acccelerated partial breast irradiation provides equivalent 10-year outcomes to whole breast irradiation: a matched-pair analysis. Am J Clin Oncol. doi:10.​1097/​COC.​0000000000000082​.
33.
Beitsch PD, Wilkinson JB, Vicini FA, et al. Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite((R)) Registry Trial. Ann Surg Oncol. 2012;19:3165–70.CrossRefPubMed
34.
Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–8.CrossRefPubMed
35.
Arthur DW, Winter K, Kuske RR, et al. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72:467–73.CrossRefPubMedPubMedCentral
36.
Khan AJ, Vicini FA, Beitsch P, et al. Local control, toxicity, and cosmesis in women > 70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Int J Radiat Oncol Biol Phys. 2012;84:323–30.CrossRefPubMed
37.
Presley CJ, Soulos PR, Herrin J, et al. Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol. 2012;30:4302–7.CrossRefPubMedPubMedCentral
38.
Vicini FA, Keisch M, Shah C, et al. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Int J Radiat Oncol Biol Phys. 2012;83:512–8.CrossRefPubMed
39.
Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–62.CrossRefPubMed
40.
Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991–9.CrossRefPubMed
41.
Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758–66.CrossRefPubMed
42.
Yashar CM, Scanderbeg D, Kuske R, Wallace A, Zannis V, Blair S, et al. Initial clinical experience with the Strut-Adjusted Volume Implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up. Int J Radiat Oncol Biol Phys. 2011;80:765–70.CrossRefPubMed
Metadata
Title
A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer
Authors
Tina J. Hieken, MD
Robert W. Mutter, MD
James W. Jakub, MD
Judy C. Boughey, MD
Amy C. Degnim, MD
William R. Sukov, MD
Stephanie Childs, MD
Kimberly S. Corbin, MD
Keith M. Furutani, PhD
Thomas J. Whitaker, PhD
Sean S. Park, MD, PhD
Publication date
01-10-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5321-1

Other articles of this Issue 10/2016

Annals of Surgical Oncology 10/2016 Go to the issue

Breast Oncology

A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer

Breast Oncology

Implementing the Prospective Surveillance Model (PSM) of Rehabilitation for Breast Cancer Patients with 1-Year Postoperative Follow-up, a Prospective, Observational Study

Breast Oncology

Complications of Oncoplastic Breast Surgery Involving Soft Tissue Transfer Versus Breast-Conserving Surgery: An Analysis of the NSQIP Database

Breast Oncology

Dense Breasts: What Do Our Patients Need to Be Told and Why?

Breast Oncology

Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer

Breast Oncology

Nipple-Sparing Mastectomy: Indications, Contraindications, Risks, Benefits, and Techniques